April 24, 2025 - 19:20

Adaptavate has successfully secured a significant investment to further its innovative low-carbon construction technology. The pre-Series A funding round saw participation from Undivided Ventures, Skreenhouse Ventures by SigmaRoc, and several other stakeholders, alongside contributions from existing investors. This financial backing highlights the growing interest and commitment to sustainable building practices within the construction industry.
The funds will be utilized to enhance the development of Adaptavate's eco-friendly materials, which aim to reduce the carbon footprint associated with traditional construction methods. By focusing on sustainability, the company is poised to make a substantial impact in a sector that is often criticized for its environmental effects.
As the demand for greener building solutions continues to rise, Adaptavate's advancements in low-carbon technology could play a crucial role in shaping the future of construction. This funding round marks a pivotal step in the company's journey towards promoting sustainable practices and reducing the industry's overall carbon emissions.
May 4, 2026 - 02:04
Archaeologists recreate Pompeii victim using AI technologyA team of archaeologists has turned to artificial intelligence to reconstruct the face of a man who died in the eruption of Mount Vesuvius nearly 2,000 years ago. The victim, whose remains were...
May 3, 2026 - 10:57
Risk, Resilience, And Humanity's Expanding Technological FrontiersAs humanity barrels toward what experts call the Convergence Age, the lines between the physical world, digital networks, and biological systems are dissolving. We are no longer just users of...
May 2, 2026 - 20:16
Business Leaders Say Adapting to AI Is Essential to SurvivalTop executives from IBM, VaynerX, and Deepblocks recently spoke to the TIME100 community about the relentless speed of change that artificial intelligence is forcing upon every industry. The...
May 2, 2026 - 02:14
A brain implant to treat depression gets FDA greenlight to start trialsA small medical device company has received permission from the U.S. Food and Drug Administration to begin testing a brain implant designed to treat depression. Motif Neurotech, the Texas-based...